Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica · Delayed Price · Currency is JMD 3.370
-0.180 (-5.07%)
At close: Mar 12, 2025
Indies Pharma Jamaica Revenue
Indies Pharma Jamaica had revenue of 270.00M JMD in the quarter ending April 30, 2025, a decrease of -10.42%. This brings the company's revenue in the last twelve months to 1.18B, up 3.94% year-over-year. In the fiscal year ending October 31, 2024, Indies Pharma Jamaica had annual revenue of 1.16B with 9.81% growth.
Revenue (ttm)
1.18B
Revenue Growth
+3.94%
P/S Ratio
3.79
Revenue / Employee
18.22M
Employees
65
Market Cap
4.49B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scotia Group Jamaica | 62.80B |
| Sagicor Group Jamaica | 107.98B |
| Barita Investments | 7.96B |
| NCB Financial Group | 135.29B |
| Pan Jamaica Group | 44.18B |
| Carreras | 21.25B |
| Wisynco Group | 56.78B |
| Seprod | 142.71B |